PPT-The Importance of Beta-Blockers in Patients with Heart Failure:

A R esynchronizationDefibrillation for A mbulatory Heart F ailure T rial RAFT Analysis L Brent Mitchell Jean L Rouleau Gary E Newton Jonathon Howlett Elizabeth . Michelle A. Hart MD CCFP . M.Sc.C.H. . Sid Feldman MD CCFP FCFP. Baycrest Health Sciences, Toronto, ON. Department of Family and Community Medicine,. University of Toronto. Faculty/Presenter Disclosure. Whistle Stop Talks. No 1. HFrEF and HFpEF . Definitions . for Diagnosis. Susie Bowell . BA Hons, RGN. Heart Failure Specialist Nurse. Primary definitions. NICE 2010 Heart Failure (HF) Guidelines (NICE). Tara Hosseinnejad, Brenda Rattanavong, Angela Y. assa. , Wai Ying Chan. Nov. 29. th. , 2016. PHM142 Fall 2016. Instructor: Dr. Jeffrey Henderson. Outline. Introduction of beta blockers. Non-selective (β. Dr. . Naser. Ashraf . Department of Basic Medical Sciences . College of Medicine . Majmaah University . Objectives . List major drug groups used in treatment of heart failure . Explain mechanism of action of digitalis and its major effects . BA (Hons) RGN. Heart Failure Specialist Nurse. RGN BA (Hons). The very essence of cardiovascular practice is the early detection of heart failure. ’. Sir Thomas Lewis, 1933. Heart Failure Definition. Mark Garcia, MD. Assistant Professor . University of New Mexico School of Medicine. Internal Medicine . Division of Cardiology. No disclosures. Leaning Objectives. Outpatient therapy focused. Understand gaps in HF therapy. Cardiology Experts in Residence: Focus on Managing Patients with Chronic Heart Failure Ileana L Piña, MD, MPH Professor, Department of Medicine Professor, Department of Epidemiology & Population Health dr.Yerizal Karani SpPD,SpJP(K). Angina Pectoris. Angina pectoris .  . sudden severe pressing chest pain or heaviness radiating to the neck, jaw, back and arms . . associated with diaphoresis, tachypnea and nausea. . Congestive Heart . Failure. Congestive Heart . Failure. Definition. Heart . failure (HF). is a condition caused by the . inability of the heart to pump sufficient blood to meet the metabolic needs of the body. Update 2 Report Date: May 2005 topic is done periodically The purpose of this report is to mcomparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are Vol. 25, No. 6 1327 May 1995:1327-32 With Beta-Adrenergic Blocking Agents After Myocardial Infarction: From Randomized Trials to Clinical Practice VISKIN, MD,* ILAN KITZIS, MD,? ELI LEV, MD, ZEEV ZA beta-blockers intoxications account for up totients. Supportive measures and the use ofdigoxin-specific antibody fragments are first line port therapy, Antidotes.Introduction. Treatment is often diffi C. Jenkins aA MD CM FRCPC Peter J. Scoates a sc MD FRCPC CONTENTS Physiology - calcium/calcium channel blockers Uses of calcium channel blockers Traditional Angina pectoris Arrhythmias Hypertension An individual patient level analysis of double-blind randomised trials. Dipak Kotecha, MBChB PhD MRCP FESC FHEA. on behalf of the . . Beta-blockers in Heart Failure Collaborative Group. Douglas Altman.